Chemours Files Standard 8-K on February 13, 2024

TL;DR

**Chemours filed a routine 8-K today, but the actual event details aren't in this snippet.**

AI Summary

The Chemours Company filed a Form 8-K with the SEC on February 13, 2024. This filing, identified by accession number 0000950170-24-014589, reports on 'Other Events' and 'Financial Statements and Exhibits' but the specific details of these events are not provided in this excerpt.

Why It Matters

This filing indicates that The Chemours Company has reported an event or information deemed material to investors, though the specific nature of the event is not detailed in the provided text.

Risk Assessment

Risk Level: low — The provided text is only the header information of an 8-K filing and does not disclose any specific events or financial impacts, thus presenting no immediate risk based on this limited information.

Key Numbers

• February 13, 2024 — Filing Date (Date of Report (Date of Earliest Event Reported))

Key Players & Entities

• The Chemours Company (company) — Registrant
• Delaware (company) — State of Incorporation
• Wilmington (company) — City of principal executive offices
• 1007 Market Street (company) — Business address street
• 19801 (company) — Business address zip code
• 46-4845564 (company) — I.R.S. Employer Identification No.
• 001-36794 (company) — Commission File Number
• 302-773-1000 (company) — Registrant's telephone number

FAQ

From the Filing

0000950170-24-014589.txt : 20240213 0000950170-24-014589.hdr.sgml : 20240213 20240213161918 ACCESSION NUMBER: 0000950170-24-014589 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24626247 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20240213.htm 8-K 8-K 0001627223 false 0001627223 2024-02-13 2024-02-13     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   February 13, 2024 Date of Report (Date of Earliest Event Reported)   The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐         Item 8.01 Other Events. On February 13, 2024, The Chemours Company issued a press release announcing the rescheduling of the release of its financial results and associated webcast conference call. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.   Item 9.01 Financial Statements and Exhibits.   (d) Exhibits 99.1 Press Release of the Company, dated February 13, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.     SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     THE